Daratumumab therapy for relapsed or refractory multiple myeloma: a single-center retrospective study

2020 ◽  
Vol 25 (12) ◽  
pp. 2151-2157
Author(s):  
Kazutaka Sunami ◽  
Hiroyuki Murakami ◽  
Hisashi Tagashira ◽  
Hiroko Ueda ◽  
Takashi Moriyama ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Retrospective Study ◽  
Single Center ◽  
Refractory Multiple Myeloma

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study

2019 ◽  
Vol 98 (6) ◽  
pp. 1441-1447 ◽  
Author(s):  
Sabrina Trudel ◽  
Benoît Tessoulin ◽  
Maxime Jullien ◽  
Nicolas Blin ◽  
Thomas Gastinne ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Retrospective Study ◽  
Real Life ◽  
Single Center ◽  
Refractory Multiple Myeloma ◽  
Real Life Setting

Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study

2019 ◽  
Vol 98 (6) ◽  
pp. 1435-1440 ◽  
Author(s):  
Maxime Jullien ◽  
Sabrina Trudel ◽  
Benoit Tessoulin ◽  
Béatrice Mahé ◽  
Viviane Dubruille ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Retrospective Study ◽  
Single Agent ◽  
Real Life ◽  
Single Center ◽  
Refractory Multiple Myeloma

Carfilzomib in Relapsed/Refractory Multiple Myeloma, Single Center Experience

2015 ◽  
Vol 15 ◽  
pp. e306-e307
Author(s):  
Y. Aydin ◽  
I. Erdogan ◽  
A. Salihoglu ◽  
T. Elverdi ◽  
F.F. Yalniz ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Single Center ◽  
Refractory Multiple Myeloma ◽  
Single Center Experience

Daratumumab for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Center Experience

2017 ◽  
Vol 17 (1) ◽  
pp. e67-e68
Author(s):  
Victor Jimenez-Zepeda ◽  
Peter Duggan ◽  
Paola Neri ◽  
Joanne Luider ◽  
Jason Tay ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Single Center ◽  
Refractory Multiple Myeloma ◽  
Single Center Experience
Sign in / Sign up

Export Citation Format

Share Document